Cost-effectiveness analysis of EGFR mutation testing in...

Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin–paclitaxel

Arrieta, Oscar, Anaya, Pablo, Morales-Oyarvide, Vicente, Ramírez-Tirado, Laura Alejandra, Polanco, Ana C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
The European Journal of Health Economics
DOI:
10.1007/s10198-015-0726-5
Date:
September, 2016
File:
PDF, 1010 KB
english, 2016
Conversion to is in progress
Conversion to is failed